Home > Term: lexatumumab
lexatumumab
A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill the tumor cells. Lexatumumab is a type of monoclonal antibody. Also called anti-TRAIL R2 mAb HGS-ETR2 and HGS-ETR2.
- Del af tale: noun
- Branche/domæne: Health care
- Category: Cancer treatment
- Company: U.S. HHS
0
Ophavsmand
- Lionel M
-
(Platinum) 5532 points - 100% positive feedback
